IL148514A0 - Compositions and methods for l-nucleosides, l-nucleotides, and their analogs - Google Patents

Compositions and methods for l-nucleosides, l-nucleotides, and their analogs

Info

Publication number: IL148514A0
Authority: IL; Israel
Prior art keywords: nucleosides; nucleotides; analogs; compositions; methods
Prior art date: 1999-12-23

Application number

IL14851400A

Original Assignee

Icn Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-23

Filing date

2000-12-19

Publication date

2002-09-12

2000-12-19 Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals

2002-09-12 Publication of IL148514A0 publication Critical patent/IL148514A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Biomedical Technology (AREA)
Environmental Sciences (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Microbiology (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Pulmonology (AREA)

IL14851400A 1999-12-23 2000-12-19 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs IL148514A0 (en)

Applications Claiming Priority (12)

Application Number	Priority Date	Filing Date	Title
US17209799P	1999-12-23	1999-12-23
US17344699P	1999-12-29	1999-12-29
US17511100P	2000-01-06	2000-01-06
US19075800P	2000-03-20	2000-03-20
US22687500P	2000-08-22	2000-08-22
US22694700P	2000-08-22	2000-08-22
US23382300P	2000-09-19	2000-09-19
US23382200P	2000-09-19	2000-09-19
US23354800P	2000-09-19	2000-09-19
US23382100P	2000-09-19	2000-09-19
US23546500P	2000-09-26	2000-09-26
PCT/US2000/034605 WO2001045509A1 (en)	1999-12-23	2000-12-19	Compositions and methods for l-nucleosides, l-nucleotides, and their analogs

Publications (1)

Publication Number	Publication Date
IL148514A0 true IL148514A0 (en)	2002-09-12

Family

ID=27582702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14851400A IL148514A0 (en)	1999-12-23	2000-12-19	Compositions and methods for l-nucleosides, l-nucleotides, and their analogs

Country Status (20)

Country	Link
EP (1)	EP1244356A4 (en)
JP (1)	JP2003523957A (en)
KR (1)	KR20030032908A (en)
CN (1)	CN1420723A (en)
AU (1)	AU2442201A (en)
BR (1)	BR0016162A (en)
CA (1)	CA2384326A1 (en)
CZ (1)	CZ20022112A3 (en)
HK (1)	HK1049944A1 (en)
HR (1)	HRP20020485A2 (en)
HU (1)	HUP0300219A3 (en)
IL (1)	IL148514A0 (en)
MX (1)	MXPA02006251A (en)
NO (1)	NO20022969L (en)
NZ (1)	NZ517634A (en)
PL (1)	PL364927A1 (en)
SI (1)	SI20976A (en)
SK (1)	SK8612002A3 (en)
WO (1)	WO2001045509A1 (en)
YU (1)	YU47802A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI332507B (en)	2002-11-19	2010-11-01	Hoffmann La Roche	Antiviral nucleoside derivatives
US6930093B2 (en) *	2003-07-10	2005-08-16	Valeant Research & Development	Use of ribofuranose derivatives against inflammatory bowel diseases
CA2537878A1 (en)	2003-09-11	2005-03-17	F. Hoffmann-La Roche Ag	Polymorphic nucleoside compounds
US20050182252A1 (en)	2004-02-13	2005-08-18	Reddy K. R.	Novel 2'-C-methyl nucleoside derivatives
EA016830B1 (en) *	2006-09-11	2012-07-30	Саузерн Рисерч Инститьют	Azole nucleosides and use as inhibitors of rna and dna varial polymerases
CN102952104A (en) *	2011-08-17	2013-03-06	黑龙江省松花江药业有限公司	Furan compound
EP3105238A4 (en)	2014-02-13	2017-11-08	Ligand Pharmaceuticals, Inc.	Prodrug compounds and their uses
JP2017520545A (en)	2014-07-02	2017-07-27	リガンド・ファーマシューティカルズ・インコーポレイテッド	Prodrug compounds and their use
CN104387431A (en) *	2014-10-24	2015-03-04	江南大学	Preparation method of high-specificity ribavirin artificial antigens
EP3156050A1 (en) *	2015-10-16	2017-04-19	Universitat Autònoma De Barcelona	New combination therapies for treating neurological damage
AU2019207625A1 (en)	2018-01-09	2020-07-30	Ligand Pharmaceuticals, Inc.	Acetal compounds and therapeutic uses thereof
CN109528638B (en) *	2018-12-20	2021-07-06	江西润泽药业有限公司	Ribavirin derivative preparation and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3798209A (en) *	1971-06-01	1974-03-19	Icn Pharmaceuticals	1,2,4-triazole nucleosides
DE3650505T2 (en) *	1986-03-27	1996-09-19	Gensia Inc	AICA riboside for the prophylactic treatment of diseases with reduced blood flow.
GB9019812D0 (en) *	1990-09-11	1990-10-24	Scotgen Ltd	Novel antibodies for treatment and prevention of infection in animals and man
US6387365B1 (en) *	1995-05-19	2002-05-14	Schering Corporation	Combination therapy for chronic hepatitis C infection
WO1997021452A2 (en) *	1995-12-14	1997-06-19	Advanced Magnetics, Inc.	Macromolecular prodrugs of nucleotide analogs
EP1027359B9 (en) *	1996-10-16	2003-09-17	Ribapharm, Inc.	Monocyclic l-nucleosides, analogs and uses thereof
SK288038B6 (en) *	1998-05-15	2013-01-02	Merck Sharp & Dohme	Use of ribavirin and interferon alpha for manufacture pharmaceutical compositions for treating chronic hepatitis C infection
US6277830B1 (en) *	1998-10-16	2001-08-21	Schering Corporation	5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
AU2026900A (en) *	1998-11-20	2000-06-13	Salk Institute For Biological Studies, The	Neuron stimulation by ribavirin, and analogs thereof

2000
- 2000-12-19 NZ NZ517634A patent/NZ517634A/en not_active Application Discontinuation
- 2000-12-19 IL IL14851400A patent/IL148514A0/en unknown
- 2000-12-19 CZ CZ20022112A patent/CZ20022112A3/en unknown
- 2000-12-19 CA CA002384326A patent/CA2384326A1/en not_active Abandoned
- 2000-12-19 EP EP00988189A patent/EP1244356A4/en not_active Withdrawn
- 2000-12-19 PL PL00364927A patent/PL364927A1/en not_active Application Discontinuation
- 2000-12-19 JP JP2001546256A patent/JP2003523957A/en active Pending
- 2000-12-19 HR HR20020485A patent/HRP20020485A2/en not_active Application Discontinuation
- 2000-12-19 HU HU0300219A patent/HUP0300219A3/en unknown
- 2000-12-19 SK SK861-2002A patent/SK8612002A3/en not_active Application Discontinuation
- 2000-12-19 WO PCT/US2000/034605 patent/WO2001045509A1/en not_active Ceased
- 2000-12-19 CN CN00817416A patent/CN1420723A/en active Pending
- 2000-12-19 BR BR0016162-4A patent/BR0016162A/en not_active IP Right Cessation
- 2000-12-19 YU YU47802A patent/YU47802A/en unknown
- 2000-12-19 HK HK03102255.3A patent/HK1049944A1/en unknown
- 2000-12-19 MX MXPA02006251A patent/MXPA02006251A/en unknown
- 2000-12-19 SI SI200020047A patent/SI20976A/en not_active IP Right Cessation
- 2000-12-19 AU AU24422/01A patent/AU2442201A/en not_active Abandoned
- 2000-12-19 KR KR1020027008069A patent/KR20030032908A/en not_active Withdrawn
2002
- 2002-06-20 NO NO20022969A patent/NO20022969L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0016162A (en)	2002-08-13
CA2384326A1 (en)	2001-06-28
MXPA02006251A (en)	2003-01-28
HUP0300219A3 (en)	2005-07-28
AU2442201A (en)	2001-07-03
SI20976A (en)	2003-02-28
NO20022969D0 (en)	2002-06-20
CN1420723A (en)	2003-05-28
EP1244356A4 (en)	2003-03-19
YU47802A (en)	2006-03-03
HK1049944A1 (en)	2003-06-06
NZ517634A (en)	2004-06-25
SK8612002A3 (en)	2003-03-04
CZ20022112A3 (en)	2003-05-14
HUP0300219A2 (en)	2003-06-28
KR20030032908A (en)	2003-04-26
NO20022969L (en)	2002-06-20
JP2003523957A (en)	2003-08-12
PL364927A1 (en)	2004-12-27
EP1244356A1 (en)	2002-10-02
WO2001045509A1 (en)	2001-06-28
HRP20020485A2 (en)	2005-10-31

Publication	Publication Date	Title
IL138280A0 (en)	2001-10-31	20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
ZA200004956B (en)	2002-02-27	Vaccine composition.
EP1294432A4 (en)	2009-06-17	Hematocrit sampling system
MXPA03004402A (en)	2003-09-05	Improved sucralose composition and process for its preparation.
PL344222A1 (en)	2001-10-08	Methods for improving seeds
HUP0202762A3 (en)	2005-04-28	Solid lipid compositions, process for their preparation and use thereof
IL148514A0 (en)	2002-09-12	Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
EG24303A (en)	2009-01-12	Buffered compositions for dialysis
GB9926161D0 (en)	2000-01-12	Methods
GB9905817D0 (en)	1999-05-05	Methods
EP1277459A4 (en)	2003-06-11	Perming compositions and perming method by using the same
GB9801870D0 (en)	1998-03-25	Vaccine composition
ZA200002546B (en)	2001-05-10	Sorbate-preserved compositions, method for the manufacture thereof and their use.
GB9823835D0 (en)	1998-12-23	Component for vaccine
ZA200202778B (en)	2003-07-09	Compositions and methods for L-nucleosides, L-nucleotides, and their analogs.
GB0002873D0 (en)	2000-03-29	Sample preparation method
GB0019210D0 (en)	2000-09-27	Contruction block
GB9908525D0 (en)	1999-06-09	Methods
GB9914943D0 (en)	1999-08-25	Methods
HRPK20000420B1 (en)	2002-06-30	Purine l-nucleosides, analogs and uses thereof
HRPK20000422B1 (en)	2002-06-30	Purine l-nucleosides, analogs and uses thereof
GB9802879D0 (en)	1998-04-08	Vaccine composition
GB9806455D0 (en)	1998-05-27	Vaccine composition
GB9824509D0 (en)	1999-01-06	Expression methods
HRPK990147B1 (en)	2002-06-30	Monocyclic l-nucleosides, analogs and uses thereof